A Comparison of Efficacy of Two Brands of Enoxaparin in COVID-19 Patients: A Pilot Study
Dhvani Dave, Jalpa Suthar & Jhanvi Patel · Asian Journal of Medicine and Health · 2022
Introduction: Enoxaparin is a complex and biologically derived low-molecular-weight Heparin which is approved for a variety of clinical indications associated with thromboembolic events such as Deep Vein Thrombosis and Venous Thromboembolism. During COVID-19 it was frequently use...
Open access
Research Article
10.9734/ajmah/2022/v20i11752